GMED
Price
$61.14
Change
+$0.01 (+0.02%)
Updated
Aug 29, 04:01 PM (EDT)
Capitalization
8.26B
74 days until earnings call
SAFLF
Price
$1.50
Change
+$0.21 (+16.28%)
Updated
Aug 13 closing price
Capitalization
700.35M
Interact to see
Advertisement

GMED vs SAFLF

Header iconGMED vs SAFLF Comparison
Open Charts GMED vs SAFLFBanner chart's image
Globus Medical
Price$61.14
Change+$0.01 (+0.02%)
Volume$400
Capitalization8.26B
Safilo Group Spa
Price$1.50
Change+$0.21 (+16.28%)
Volume$126.74K
Capitalization700.35M
GMED vs SAFLF Comparison Chart in %
Loading...
GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GMED vs. SAFLF commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMED is a StrongBuy and SAFLF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (GMED: $61.13 vs. SAFLF: $1.50)
Brand notoriety: GMED and SAFLF are both not notable
GMED represents the Medical/Nursing Services, while SAFLF is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: GMED: 51% vs. SAFLF: 390%
Market capitalization -- GMED: $8.26B vs. SAFLF: $700.35M
GMED [@Medical/Nursing Services] is valued at $8.26B. SAFLF’s [@Pharmaceuticals: Other] market capitalization is $700.35M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $228.64B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.86B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GMED’s FA Score shows that 0 FA rating(s) are green whileSAFLF’s FA Score has 0 green FA rating(s).

  • GMED’s FA Score: 0 green, 5 red.
  • SAFLF’s FA Score: 0 green, 5 red.
According to our system of comparison, SAFLF is a better buy in the long-term than GMED.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GMED’s TA Score shows that 5 TA indicator(s) are bullish while SAFLF’s TA Score has 3 bullish TA indicator(s).

  • GMED’s TA Score: 5 bullish, 5 bearish.
  • SAFLF’s TA Score: 3 bullish, 1 bearish.
According to our system of comparison, SAFLF is a better buy in the short-term than GMED.

Price Growth

GMED (@Medical/Nursing Services) experienced а +1.04% price change this week, while SAFLF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.88%. For the same industry, the average monthly price growth was +6.74%, and the average quarterly price growth was +10.13%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.47%. For the same industry, the average monthly price growth was +5.74%, and the average quarterly price growth was +15.16%.

Reported Earning Dates

GMED is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Medical/Nursing Services (+0.88% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+0.47% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GMED($8.26B) has a higher market cap than SAFLF($700M). GMED has higher P/E ratio than SAFLF: GMED (23.69) vs SAFLF (11.51). SAFLF YTD gains are higher at: 53.014 vs. GMED (-26.091). GMED has higher annual earnings (EBITDA): 620M vs. SAFLF (107M). GMED has more cash in the bank: 229M vs. SAFLF (72.6M). SAFLF has less debt than GMED: SAFLF (115M) vs GMED (121M). GMED has higher revenues than SAFLF: GMED (2.63B) vs SAFLF (999M).
GMEDSAFLFGMED / SAFLF
Capitalization8.26B700M1,179%
EBITDA620M107M579%
Gain YTD-26.09153.014-49%
P/E Ratio23.6911.51206%
Revenue2.63B999M263%
Total Cash229M72.6M315%
Total Debt121M115M105%
FUNDAMENTALS RATINGS
GMED vs SAFLF: Fundamental Ratings
GMED
SAFLF
OUTLOOK RATING
1..100
7950
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
7777
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5737
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a33

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SAFLF's Valuation (62) in the null industry is in the same range as GMED (75) in the Medical Specialties industry. This means that SAFLF’s stock grew similarly to GMED’s over the last 12 months.

SAFLF's Profit vs Risk Rating (77) in the null industry is in the same range as GMED (77) in the Medical Specialties industry. This means that SAFLF’s stock grew similarly to GMED’s over the last 12 months.

SAFLF's SMR Rating (100) in the null industry is in the same range as GMED (100) in the Medical Specialties industry. This means that SAFLF’s stock grew similarly to GMED’s over the last 12 months.

SAFLF's Price Growth Rating (37) in the null industry is in the same range as GMED (57) in the Medical Specialties industry. This means that SAFLF’s stock grew similarly to GMED’s over the last 12 months.

SAFLF's P/E Growth Rating (100) in the null industry is in the same range as GMED (100) in the Medical Specialties industry. This means that SAFLF’s stock grew similarly to GMED’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GMEDSAFLF
RSI
ODDS (%)
Bearish Trend 2 days ago
59%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
43%
Momentum
ODDS (%)
Bullish Trend 2 days ago
68%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
37%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
27%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
22%
Advances
ODDS (%)
Bullish Trend 17 days ago
65%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
59%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
60%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
48%
View a ticker or compare two or three
Interact to see
Advertisement
GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MABAX20.43N/A
N/A
BlackRock Large Cap Focus Value Instl
HIMCX24.87N/A
N/A
Hartford MidCap HLS IA
CSRIX49.60N/A
N/A
Cohen & Steers Instl Realty Shares
PJECX15.14N/A
N/A
PGIM US Real Estate C
JMCRX22.44N/A
N/A
James Micro Cap

GMED and

Correlation & Price change

A.I.dvisor indicates that over the last year, GMED has been loosely correlated with VREX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if GMED jumps, then VREX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMED
1D Price
Change %
GMED100%
-0.62%
VREX - GMED
52%
Loosely correlated
+0.17%
CVRX - GMED
49%
Loosely correlated
+4.23%
CTKB - GMED
49%
Loosely correlated
+1.96%
ITGR - GMED
45%
Loosely correlated
-0.64%
TMCI - GMED
44%
Loosely correlated
-0.27%
More

SAFLF and

Correlation & Price change

A.I.dvisor tells us that SAFLF and GMED have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SAFLF and GMED's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAFLF
1D Price
Change %
SAFLF100%
N/A
GMED - SAFLF
28%
Poorly correlated
-0.62%
MYGN - SAFLF
24%
Poorly correlated
+4.89%
JMPHF - SAFLF
23%
Poorly correlated
N/A
OFIX - SAFLF
22%
Poorly correlated
-0.67%
MROPF - SAFLF
21%
Poorly correlated
N/A
More